AbbVie Delivers on Earnings and Raises Forecast – Barron’s

The drug company
delivered what Wall Street expected in the third quarter of its fiscal year, reporting adjusted diluted earnings per share of $2.33, slightly beating the S&P Capital IQ Consensus of $2.30.AbbVie (ticker: ABBV) reported net re…

Click here to view the original article.